Punjab Chemicals & Crop Protection Ltd

- There is no specific mention of any current or planned new fundraising through debt or equity in the provided excerpts. - The company is focusing on capex for a new facility related to phosphorus chemistry, with details and amounts expected to be shared by Q2 next year (Page 8). - Discussions around investments are ongoing, for example, joint investments with customers for new facilities (Page 13-14). - The company is managing expenses related to asset upgradation and maintenance primarily through internal resources (Page 12). - No explicit statements or guidance about raising capital via equity or debt were provided in the call transcript.

- A new phosphoric acid facility is planned between Maharashtra and Gujarat, fast-tracked after a prior site was dropped for legal reasons. Exact capex details expected by Q2 FY '26. (Page 8) - INR 15-18 crores spent recently on onetime expenses for asset renewal, new reactors, columns, and HSE improvements. (Page 8) - Existing plants are undergoing process improvements and debottlenecking to cater to increasing demand without immediate large capex. (Page 7) - Considering outsourcing some operations to nearby facilities to capture demand upside while new greenfield projects take shape. (Page 7) - Industrial Chemicals division's new greenfield facility expected by late FY '26 or early FY '27, involving joint investment with a customer. (Page 13) - Current capital investments focused on enhancing capacity utilization and new product scale-up at Lalru plant under new factory manager. (Page 15)

- The Industrial Chemicals business aims to more than double revenue from around INR130 crore to approximately INR300 crore in the next 2 years. - A new greenfield facility is planned between Maharashtra and Gujarat to expand phosphorus chemistry capacity, with commercialization targeted by late FY '26 or early FY '27. - Discussions with customers signal addition of new specialty and intermediates products, expected to contribute to sales growth starting FY '26. - Export demand, currently subdued, is expected to recover gradually by Q2-Q3 FY '26, improving volumes and margins. - Domestic market focus is increasing with new molecules contributing about 15% of revenues and expected to grow as market shares mature. - Capacity utilization improvements and process debottlenecking are planned to support higher volumes without immediate major capex. - Overall, revenue growth of 12-14% is targeted for the next financial year with steady margin improvements.

- The company expects a revenue jump of 12%-14% in the next financial year (Page 8). - Industrial Chemicals division aims to double revenues in the next 2 years, growing from around INR130 crore to about INR300 crore (Pages 13-14). - EBITDA margins for phosphoric acid business are expected between 18%-20% (Page 15). - Overall EBITDA margin guidance suggests improving from single digits currently to around 12%-14%, eventually targeting 15%-18% (Page 9). - New product launches and expanding domestic market share (currently contributing ~15% revenue from new products) are expected to enhance margins (Pages 4, 9). - Capacity utilization for agrochemical division is at 72%, performance chemicals at 52%, with expansion plans underway, supporting growth (Page 3). - The launch of new facilities and process improvements will further support scaling revenues and margins in coming years (Pages 7-8, 14-15).

- There is no specific quantitative disclosure of the current or expected order book in the transcript. - Discussions indicate robust ongoing order flow, especially in new product launches and domestic market expansion. - New orders in Industrial Chemicals involve partnerships with customers including a beverage company, with execution expected in FY '26. - Capacity constraints at Pune plant are addressed by exploring outsourcing and process improvements; a greenfield facility is planned for commercialization by late FY '26 or early FY '27. - The product pipeline is strong with multiple new molecules under development and expected launches in the near term. - Export demand is expected to recover gradually over 2-3 quarters from Q3 FY '25, which will positively impact order inflow. - Management expresses confidence in healthy demand forecasts for Q4, Q1, and Q2 of next financial year.